Synthetic Essentiality of Chromatin Remodelling Factor CHD1 in PTEN-deficient Cancer

Established the principle of “synthetic essentiality” and identified CHD1 as a synthetic-essential gene in PTEN-deficient cancers. This study identified a novel PTEN pathway in cancer and provided a framework for the discovery of ‘trackable’ targets in cancers that harbor specific tumor-suppressor deficiencies.

Read the Abstract

Download the PDF

Get Insights From Ron

Sign up for the latest news and updates from Ron DePinho, MD